Efficacy of OnabotulinumtoxinA in Migraine

NCT04578782 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Migraine

Interventions

DRUG: OnabotulinumtoxinA

Sponsor

IRCCS National Neurological Institute "C. Mondino" Foundation